首页> 外文期刊>Acta Neurochirurgica >Fatal tumoral hemorrhage after stereotactic radiosurgery for metastatic brain tumors: Report of three cases and review of literature
【24h】

Fatal tumoral hemorrhage after stereotactic radiosurgery for metastatic brain tumors: Report of three cases and review of literature

机译:立体定向放射外科治疗转移性脑肿瘤后的致命肿瘤出血:三例报告并文献复习

获取原文
获取原文并翻译 | 示例
           

摘要

Acute tumor hemorrhage occurring during stereotactic radiosurgery (SRS) for a metastatic lesion, or in the immediate post-treatment period, is believed to be extremely rare. The potential risk of hemorrhage related to SRS procedures in patients with metastatic brain tumors is not yet clearly understood. This case report describes three patients suffering acute fatal tumor hemorrhage during or immediately after SRS. One patient died within 2 weeks of treatment and the other patients were severely disabled as a result of the hemorrhage. The incidence of this complication was estimated as 0.52% per patient, 0.33% per intervention and 0.08% per lesion by reviewing our research database. Metastases from renal cell carcinoma, evidence of preradiosurgical peritumoral oozing of blood, anti-coagulant and anti-platelet therapy were likely to be associated with tumor hemorrhage. Although this life-threatening complication is uncommon, extra caution should be exercised when treating patients with factors that could predispose to tumoral hemorrhage.
机译:据信在转移性病变的立体定向放射外科手术(SRS)期间或治疗后即刻发生的急性肿瘤出血极为罕见。目前尚不清楚转移性脑肿瘤患者与SRS手术相关的潜在出血风险。该病例报告描述了三名在SRS期间或之后遭受急性致命性肿瘤出血的患者。一名患者在治疗后2周内死亡,另一名患者因出血而严重残疾。通过审查我们的研究数据库,该并发症的发生率估计为每例患者0.52%,每次干预0.33%和每个病变0.08%。肾细胞癌转移,放射外科手术前肿瘤周围渗血,抗凝和抗血小板治疗的证据可能与肿瘤出血有关。尽管这种危及生命的并发症并不常见,但是在治疗可能导致肿瘤出血的因素时应格外小心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号